Annual FCF
-$8.10 M
-$536.00 K-7.09%
December 31, 2022
Summary
- As of February 10, 2025, BVXV annual free cash flow is -$8.10 million, with the most recent change of -$536.00 thousand (-7.09%) on December 31, 2022.
- During the last 3 years, BVXV annual FCF has risen by +$16.30 million (+66.80%).
Performance
BVXV Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$3.25 M
-$188.00 K-6.13%
June 30, 2023
Summary
- As of February 10, 2025, BVXV quarterly free cash flow is -$3.25 million, with the most recent change of -$188.00 thousand (-6.13%) on June 30, 2023.
- Over the past year, BVXV quarterly FCF has increased by +$377.00 thousand (+10.39%).
Performance
BVXV Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$6.32 M
+$377.00 K+5.63%
June 30, 2023
Summary
- As of February 10, 2025, BVXV TTM free cash flow is -$6.32 million, with the most recent change of +$377.00 thousand (+5.63%) on June 30, 2023.
- Over the past year, BVXV TTM FCF has dropped by -$1.06 million (-20.21%).
Performance
BVXV TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BVXV Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.1% | +10.4% | -20.2% |
| 3 y3 years | +66.8% | - | - |
| 5 y5 years | -93.4% | +73.2% | - |
BVXV Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +7.1% | at low | +100.1% | +11.6% | +288.6% | +6.0% |
| 5 y | 5-year | +7.1% | +202.0% | +100.1% | +11.6% | +288.6% | +6.0% |
| alltime | all time | +541.1% | +202.0% | +1115.6% | +273.3% | +1195.2% | +240.1% |
BiondVax Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$3.25 M(+6.1%) | -$6.32 M(-5.6%) |
| Mar 2023 | - | -$3.06 M(-15.6%) | -$6.70 M(+27.4%) |
| Dec 2022 | -$8.10 M(+7.1%) | - | - |
| Jun 2022 | - | -$3.63 M(+123.2%) | -$5.26 M(+223.2%) |
| Mar 2022 | - | -$1.63 M(-74.9%) | -$1.63 M(-89.7%) |
| Dec 2021 | -$7.57 M(-69.1%) | - | - |
| Dec 2020 | -$24.47 M(+0.3%) | - | - |
| Dec 2019 | -$24.40 M(+13.6%) | - | - |
| Jun 2019 | - | -$6.49 M(+43.3%) | -$15.74 M(-26.4%) |
| Mar 2019 | - | -$4.53 M(+129.9%) | -$21.39 M(-0.4%) |
| Dec 2018 | -$21.49 M(+413.0%) | -$1.97 M(-28.5%) | -$21.49 M(+2.2%) |
| Sep 2018 | - | -$2.75 M(-77.3%) | -$21.01 M(+8.4%) |
| Jun 2018 | - | -$12.14 M(+162.8%) | -$19.39 M(+137.7%) |
| Mar 2018 | - | -$4.62 M(+208.8%) | -$8.15 M(+94.7%) |
| Dec 2017 | -$4.19 M | -$1.50 M(+33.0%) | -$4.19 M(+28.7%) |
| Sep 2017 | - | -$1.13 M(+23.4%) | -$3.26 M(+35.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$911.70 K(+39.1%) | -$2.40 M(+3.6%) |
| Mar 2017 | - | -$655.20 K(+16.2%) | -$2.31 M(-8.0%) |
| Dec 2016 | -$2.51 M(-4.7%) | -$563.70 K(+110.7%) | -$2.51 M(-7.8%) |
| Sep 2016 | - | -$267.60 K(-67.7%) | -$2.73 M(-11.2%) |
| Jun 2016 | - | -$827.70 K(-3.3%) | -$3.07 M(+2.3%) |
| Mar 2016 | - | -$855.70 K(+10.4%) | -$3.00 M(+13.7%) |
| Dec 2015 | -$2.64 M(+35.2%) | -$775.00 K(+27.0%) | -$2.64 M(+12.3%) |
| Sep 2015 | - | -$610.20 K(-19.6%) | -$2.35 M(+6.9%) |
| Jun 2015 | - | -$759.40 K(+53.7%) | -$2.20 M(+12.2%) |
| Mar 2015 | - | -$494.10 K(+1.6%) | -$1.96 M(+0.3%) |
| Dec 2014 | -$1.95 M(+54.5%) | -$486.30 K(+6.3%) | -$1.95 M(+33.2%) |
| Sep 2014 | - | -$457.50 K(-12.2%) | -$1.47 M(+45.4%) |
| Jun 2014 | - | -$520.80 K(+6.8%) | -$1.01 M(+106.8%) |
| Mar 2014 | - | -$487.80 K | -$487.80 K |
| Dec 2013 | -$1.26 M(-35.4%) | - | - |
| Dec 2012 | -$1.96 M(-39.9%) | - | - |
| Dec 2011 | -$3.26 M | - | - |
FAQ
- What is BiondVax Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual FCF year-on-year change?
- What is BiondVax Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly FCF year-on-year change?
- What is BiondVax Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals TTM FCF year-on-year change?
What is BiondVax Pharmaceuticals annual free cash flow?
The current annual FCF of BVXV is -$8.10 M
What is the all time high annual FCF for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual free cash flow is -$1.26 M
What is BiondVax Pharmaceuticals annual FCF year-on-year change?
Over the past year, BVXV annual free cash flow has changed by -$536.00 K (-7.09%)
What is BiondVax Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of BVXV is -$3.25 M
What is the all time high quarterly FCF for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly free cash flow is -$267.60 K
What is BiondVax Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, BVXV quarterly free cash flow has changed by +$377.00 K (+10.39%)
What is BiondVax Pharmaceuticals TTM free cash flow?
The current TTM FCF of BVXV is -$6.32 M
What is the all time high TTM FCF for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high TTM free cash flow is -$487.80 K
What is BiondVax Pharmaceuticals TTM FCF year-on-year change?
Over the past year, BVXV TTM free cash flow has changed by -$1.06 M (-20.21%)